Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591–602. https://doi.org/10.1002/ijc.21683.

Article  PubMed  CAS  Google Scholar 

Gupta P, Meghashyam K, Marodia Y, Gupta V, Basher R, Das CK, Yadav TD, Irrinki S, Nada R, Dutta U. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol (NY). 2021;46(3):998–1007. https://doi.org/10.1007/s00261-020-02756-4.

Article  PubMed  Google Scholar 

Kondo S, Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Hayakawa N. Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbecks Arch Surg. 2002;387(5–6):222–8. https://doi.org/10.1007/s00423-002-0318-6.

Article  PubMed  Google Scholar 

Aggarwal A, Goel S, Sayed AI, Goel V, Talwar V, Singh S. Interaortocaval lymph node metastasis in gall bladder cancer: is it regional node or metastatic disease? J Gastrointest Cancer. 2023;54(4):1252–60. https://doi.org/10.1007/s12029-023-00914-7.

Article  PubMed  CAS  Google Scholar 

Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg. 2007;14(4):351–7. https://doi.org/10.1007/s00534-006-1187-0.

Article  PubMed  Google Scholar 

Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Kobayashi H, Sueda T. Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma? World J Surg. 2011;35(5):1085–93. https://doi.org/10.1007/s00268-011-1036-4.

Article  PubMed  Google Scholar 

Bisht N, Lohia N, Singh S, Sarin A, Mahato A, Paliwal D, Sinha I, Bhatnagar S. Utility of 18-flurodeoxyglucose positron emission tomography-computed tomography (18 FDG PET-CT) in gallbladder cancer: experience from a tertiary care hospital. World J Nucl Med. 2023;22(4):276–83. https://doi.org/10.1055/s-0043-1777699.

Article  PubMed  PubMed Central  Google Scholar 

Chaudhari VA, Ostwal V, Patkar S, Sahu A, Toshniwal A, Ramaswamy A, Shetty NS, Shrikhande SV, Goel M. Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications. HPB (Oxford). 2018;20(9):841–7. https://doi.org/10.1016/j.hpb.2018.03.008.

Article  PubMed  Google Scholar 

Agrawal S, Gupta A, Kapoor V, Rahul R, Singh A, Mishra P, Saxena R. Predictors of toxicity in a randomized study of consolidation chemoradiation versus observation after first line chemotherapy in advanced gall bladder cancers. Adv Radiat Oncol. 2024;9(5):101468. https://doi.org/10.1016/j.adro.2024.101468.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L. RECIST 1.1-update and clarification: from the RECIST committee. Eur J Cancer. 2016;62:132–7. https://doi.org/10.1016/j.ejca.2016.03.081.

Article  PubMed  PubMed Central  Google Scholar 

Tsukada K, Kurosaki I, Uchida K, Shirai Y, Oohashi Y, Yokoyama N, Watanabe H, Hatakeyama K. Lymph node spread from carcinoma of the gallbladder. Cancer. 1997;80(4):661–7.

Article  PubMed  CAS  Google Scholar 

Alam MN, Agrawal S, Rastogi N, Maria Das KJ. Consolidation chemoradiation (cCTRT) improves survival in responders to first-line chemotherapy (CT) in locally advanced gallbladder cancer (LA-GBC): a new standard of care? Indian J Cancer. 2022;59(4):577–83. https://doi.org/10.4103/ijc.IJC_1145_20.

Article  PubMed  Google Scholar 

Fuller CD, Thomas CR Jr, Wong A, et al. Image-guided intensity-modulated radiation therapy for gallbladder carcinoma. Radiother Oncol. 2006;81(1):65–72.

Article  PubMed  Google Scholar 

Das R, Abbott MR, Hadley SW, et al. Predictors of acute and late toxicity in patients receiving chemoradiation for unresectable pancreatic cancer. Adv Radiat Oncol. 2023;8(6):101266.

Article  PubMed  PubMed Central  Google Scholar 

Goel S, Aggarwal A, Iqbal A, Talwar V, Mitra S, Singh S. Multimodality management of gallbladder cancer can lead to a better outcome: experience from a tertiary care oncology centre in North India. World J Gastroenterol. 2021;27(45):7813–30. https://doi.org/10.3748/wjg.v27.i45.7813.

Article  PubMed  PubMed Central  Google Scholar 

Agrawal S, Rahul R, Singh A, Saxena R. Feasibility and outcome of neoadjuvant strategies in advanced gallbladder cancer (GBC). Radiother Oncol. 2024;194(suppl 1):2204–5.

Google Scholar 

Shroff RT, Javle MM, Xiao L, et al. Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial. JAMA Oncol. 2019;5(6):824–30. https://doi.org/10.1001/jamaoncol.2019.0270.

Article  PubMed  PubMed Central  Google Scholar 

Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Mitsuhashi N, Takeuchi D, Suda K, Yoshioka I, Miyazaki M. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. J Hepatobiliary Pancreat Surg. 2007;14(4):358–65. https://doi.org/10.1007/s00534-006-1188-z.

Article  PubMed  Google Scholar